Sign up for the QMED & MD+DI Daily newsletter.
May 26, 2021
Since the beginning of the year, it seems, all eyes have been on the second half of 2021 as medtech companies were still grappling with a lot of uncertainty heading into 2021. Now that we're well into the second quarter, here are some key takeaways from first-quarter earnings calls from a handful of medtech companies that were most impacted by COVID-19 disruptions and lower procedure volumes.
About the Author(s)
You May Also Like
Get Your Melons Checked at WalmartMar 4, 2024|3 Min Read
Medtech in a Minute: Integra's Bold Decision, and MoreMar 4, 2024|1 Min Read
Medtronic Won't Back Down but Axonics Stands Its GroundMar 4, 2024|3 Min Read
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read